HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $1.2M of Halozyme Therapeutics, Inc.
Sold$1,249,096
$62.45Price
20,000Shares
−10%Stake
What HALO did after the filing
- The stock from Wed, Sep 18 close, $62.31
- −18.8%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Oct 30 close.
Traded Tue, Sep 17. Filed Wed, Sep 18, 2:49 PM ET, during the session. Returns use the Sep 18 close and the Oct 30 close. Not investment advice.